China Pharma Holdings (CPHI) FCF Margin (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly FCF Margin came in at 5.62% in Q1 2026, up 600.0% YoY from 0.8% in Q1 2025, and down 145.48% on a QoQ basis from 12.36% in Q4 2025.
China Pharma Holdings (CPHI) FCF Margin (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of FCF Margin data on file, last reported at 5.62% in Q1 2026.
- Quarterly FCF Margin rose 600.0% year-over-year to 5.62% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.15% (up 329.0% YoY) and the FY2025 annual result came in at 2.15%, up 1196.0% from the prior year.
- FCF Margin eased to 5.62% in Q1 2026, from 12.36% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 52.11% in Q3 2023 to a low of 72.04% in Q1 2023.
- A 5-year average of 8.44% and a median of 5.62% in 2026 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin plunged 5955 bps — and 2023, when it soared 5381 bps.
- Tracing CPHI's FCF Margin over 5 years: stood at 20.95% in 2022, then slumped by 106 bps to 1.25% in 2023, then jumped by 2071 bps to 24.62% in 2024, then tumbled by 50 bps to 12.36% in 2025, then plunged by 145 bps to 5.62% in 2026.
- The last three FCF Margin figures came in at 5.62% (Q1 2026), 12.36% (Q4 2025), and 31.42% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | -3.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.62% |
| Dec 31, 2025 | 12.36% |
| Sep 30, 2025 | -31.42% |
| Jun 30, 2025 | 29.93% |
| Mar 31, 2025 | -11.62% |
| Dec 31, 2024 | 24.62% |
| Sep 30, 2024 | -3.43% |
| Jun 30, 2024 | -7.86% |
| Mar 31, 2024 | -42.72% |
| Dec 31, 2023 | -1.25% |
| Sep 30, 2023 | 52.11% |
| Jun 30, 2023 | -19.30% |
| Mar 31, 2023 | -72.04% |
| Dec 31, 2022 | 20.95% |
| Sep 30, 2022 | -1.70% |
| Jun 30, 2022 | -31.56% |
| Mar 31, 2022 | -54.91% |
| Dec 31, 2021 | -7.10% |
| Sep 30, 2021 | -43.81% |
| Jun 30, 2021 | 27.99% |